[1. Memedi R, Tasic V, Nikolic E, Jancevska A, Gucev Z. Obesity in childhood and adolescence, genetic factors. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2013;34(2):85-89.]Search in Google Scholar
[2. Wang Y, Lobstein T. Worldwide trends in childhood overweight and obesity. Int J Pediatr Obes. 2006;1(1):11-25.10.1080/17477160600586747]Search in Google Scholar
[3. Ebbeling CB, Pawlak DB, Ludwig DS. Childhood obesity: publichealth crisis, common sense cure. Lancet. 2002;360(9331):473–482.10.1016/S0140-6736(02)09678-2]Search in Google Scholar
[4. Krstevska-Konstantinova M, Jancevska A, Kocova M, Gucev Z. Weight, height and puberty in a cohort of Macedonian girls. Med Arh. 2009;63(2):80-1.]Search in Google Scholar
[5. Ogden CL, Carroll MD, Flegal KM. High body mass index for age among US children and adolescents, 2003–2006. JAMA. 2008;299(20):2401-2405.10.1001/jama.299.20.2401]Search in Google Scholar
[6. Kipping RR, Jago R, Lawlor DA. Obesity in children. Part 1: epidemiology, measurement, risk factors, and screening. BMJ. 2008;337:a1824.10.1136/bmj.a1824]Search in Google Scholar
[7. Sundblom E, Petzold M, Rasmussen F, Callmer E, Lissner L. Childhood overweight and obesity prevalences levelling off in Stockholm but socioeconomic diff erences persist. Int J Obes (Lond). 2008;32(10):1525-1530.10.1038/ijo.2008.104]Search in Google Scholar
[8. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240-1243.10.1136/bmj.320.7244.1240]Search in Google Scholar
[9. Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. The national health and nutrition examination surveys, 1963 to 1991. Arch Pediatr Adolesc Med. 1995;149(10):1085-1091.10.1001/archpedi.1995.02170230039005]Search in Google Scholar
[10. Neovius MG, Linne YM, Barkeling BS, Rossner SO. Sensitivity and specificity of classification systems for fatness in adolescents. Am J Clin Nutr. 2004;80(3):597-603.10.1093/ajcn/80.3.597]Search in Google Scholar
[11. Unger RH. The hyperleptinemia of obesity regulator of caloric surpluses. Cell. 2004;117(2):145-146.10.1016/S0092-8674(04)00339-3]Search in Google Scholar
[12. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387(6636):903-1103.10.1038/431859202122]Search in Google Scholar
[13. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T-cell hyporesponsivness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110(8):1093-1103.10.1172/JCI0215693]Search in Google Scholar
[14. Waalen, J. The genetics of human obesity. Transl Res. 2014;164(4):293-301.10.1016/j.trsl.2014.05.01024929207]Search in Google Scholar
[15. Cassidy SB, Driscoll DJ. Prader-Willi syndrome. Eur J Hum Genet. 2009;17(1):3-13.10.1038/ejhg.2008.165298596618781185]Open DOISearch in Google Scholar
[16. Butler, MG. Prader-Willi syndrome: obesity due to genomic imprinting. Curr Genomics. 2011;12(3):204-215.10.2174/138920211795677877313700522043168]Open DOISearch in Google Scholar
[17. Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest. 2015;38:1249-1263.10.1007/s40618-015-0312-9463025526062517]Search in Google Scholar
[18. Sahoo T, Gaudio D, German JR, et al. Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster. Nat Genet. 2008;40(6):719-721.10.1038/ng.158270519718500341]Search in Google Scholar
[19. Jong MT, Carey AH, Caldwell KA, et al. Imprinting of a RING zinc-finger encoding gene in the mouse chromosome region homologous to the Prader-Willi syndrome genetic region. Hum Mol Genet. 1999;8(5):795-803.10.1093/hmg/8.5.79510196368]Open DOISearch in Google Scholar
[20. Boccaccio I, Glatt-Deeley H, Watrin F, Roeckel N, Lalande M, Muscatelli F. The human MAGEL2 gene and its mouse homologue are paternally expressed and mapped to the Prader-Willi region. Hum Mol Genet. 1999;8(13):2497-2505.10.1093/hmg/8.13.249710556298]Search in Google Scholar
[21. MacDonald HR, Wevrick R. The necdin gene is deleted in Prader-Willi syndrome and is imprinted in human and mouse. Hum Mol Genet. 1997;6(11):1873-1878.10.1093/hmg/6.11.18739302265]Open DOISearch in Google Scholar
[22. Farber C, Gross S, Neesen J. Buiting K. Horsthemke B. Identification of a testis-specific gene (C15orf2) in the Prader-Willi syndrome region on chromosome 15. Genomics. 2000;65(2):174-183.10.1006/geno.2000.615810783265]Open DOISearch in Google Scholar
[23. Griggs J, Sinnayah P, Mathai, ML. Prader-Willi syndrome: from genetics to behaviour, with special focus on appetite treatments. Neurosci Biobehav Rev. 2015;59:155-172.10.1016/j.neubiorev.2015.10.00326475993]Search in Google Scholar
[24. M’Hamdi O, Ouertani I, Chaabouni-Bouhamed H. Update on the genetics of Bardet-Biedl syndrome. Mol Syndromol. 2014;5(2):51-56.10.1159/000357054397722324715851]Search in Google Scholar
[25. Forsythe E, Beales PL. Bardet-Biedl syndrome. Eur J Hum Genet. 2013;21(1):8–1310.1038/ejhg.2012.115352219622713813]Open DOISearch in Google Scholar
[26. Brown JM, Witman GB. Cilia and diseases. Bioscience. 2014;64:1126-1137.10.1093/biosci/biu174442026125960570]Open DOISearch in Google Scholar
[27. Seo S, Guo DF, Bugge K., Morgan DA, Rahmouni K, SheffieldnVC. Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling. Hum Mol Genet. 2009;18(7):1323-1331.10.1093/hmg/ddp031265577319150989]Open DOISearch in Google Scholar
[28. Ristoska Bojkovska N, Spahiu L, Janchevska A, Gucev ZS, Tasic V. Renal dysplasia in Bardet-Biedl syndrome. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2015;36(1):211-215.10.1515/prilozi-2015-0048]Search in Google Scholar
[29. Marshall JD, Bronson RT, Collin GB, et al. New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch Intern Med. 2005;165(6):675-683.10.1001/archinte.165.6.67515795345]Search in Google Scholar
[30. Pagon RA, Adam MP, Ardinger HH, et al., editors. Seattle (WA): University of Washington, Seattle; 1993-2017.]Search in Google Scholar
[31. Collin GB, Marshall JD, Ikeda A, et al. Mutations in ALMS1 cause obesity, type 2 diabetes and neurosensory degeneration in Alstrom syndrome. Nat Genet. 2002;31(1):74-78.10.1038/ng86711941369]Open DOISearch in Google Scholar
[32. Wang L, Shoemaker AH. Eating behaviors in obese children with pseudohypoparathyroidism type 1a: a cross-sectional study. Int J Pediatr Endocrinol. 2014;2014(1):21.10.1186/1687-9856-2014-21420477725337124]Search in Google Scholar
[33. Turan S, Bastepe M. GNAS spectrum of disorders. Curr Osteoporos Rep. 2015;13(3):146-158.10.1007/s11914-015-0268-x441743025851935]Search in Google Scholar
[34. Levine MA. An update on the clinical and molecular characteristics of pseudohypoparathyroidism. Curr Opi Endocrinol Diabetes Obes. 2012;19(6):443-451.10.1097/MED.0b013e32835a255c367953523076042]Search in Google Scholar
[35. Rivera-Brugues N, Albrecht B, Wieczorek D, et al. Cohen syndrome diagnosis using whole genome arrays. J Med Genet. 2011;48(2):136-140.10.1136/jmg.2010.08220620921020]Open DOISearch in Google Scholar
[36. Kolehmainen J, Black GC, Saarinen A, et al. Cohen syndrome is caused by mutations in a novel gene, COH1, encoding a transmembrane protein with a presumed role in vesicle-mediated sorting and intracellular protein transport. Am J Hum Genet. 2003;72(6):1359-1369.10.1086/375454118029812730828]Search in Google Scholar
[37. Miyake N, Koshimizu E, Okamoto N, et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome. Am J Med Genet. 2013;161A(9):2234-2243.10.1002/ajmg.a.3607223913813]Search in Google Scholar
[38. Ng SB, Bigham AW, Buckingham K.J et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet. 2010;42(9):790-793.10.1038/ng.646293002820711175]Open DOISearch in Google Scholar
[39. Lederer D, Grisart B, Digilio MC, et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet. 2012;90(1):119-124.10.1016/j.ajhg.2011.11.021325787822197486]Search in Google Scholar
[40. Paulussen AD, Stegmann AP, Blok MJ, et al. MLL2 mutation spectrum in 45 patients with Kabuki syndrome. Hum Mutat. 2011;32(2):E2018-E2025.10.1002/humu.2141621280141]Open DOISearch in Google Scholar
[41. Turner G, Lower KM, White SM, et al. The clinical picture of the Borjeson-Forssman-Lehmann syndrome in males and heterozygous females with PHF6 mutations. Clin Genet. 2004;65(3):226-232.10.1111/j.0009-9163.2004.00215.x14756673]Open DOISearch in Google Scholar
[42. Lower KM, Turner G, Kerr BA, et al. Mutations in PHF6 are associated with Borjeson-Forssman-Lehmann syndrome. Nat Genet. 2002;32(4):661-665.10.1038/ng104012415272]Open DOISearch in Google Scholar
[43. Cohen DM, Green JG, Miller J, Gorlin RJ, Reed JA. Acrocephalopolysyndactyly type II–Carpenter syndrome: clinical spectrum and an attempt at unification with Goodman and Summit syndromes. Am J Med Genet. 1987;28(2):311-324.10.1002/ajmg.13202802083322002]Open DOISearch in Google Scholar
[44. Alessandri JL, Dagoneau N, Laville JM, Baruteau J, Hebert JC, Cormier-Daire V. RAB23 mutation in a large family from Comoros Islands with Carpenter syndrome. Am J Med Genet. 2010;152A(4):982-986.10.1002/ajmg.a.3332720358613]Search in Google Scholar
[45. Jenkins D, Baynam G, Catte L. Carpenter syndrome: extended RAB23 mutation spectrum and analysis of nonsense-mediated mRNA decay. Hum Mutat. 2011;32(4):E2069-E2078.10.1002/humu.21457342986821412941]Open DOISearch in Google Scholar
[46. Chen L, Mullegama SV, Alaimo JT, Elsea SH. Smith-Magenis syndrome and its circadian influence on development, behavior, and obesity – own experience. Dev Period Med. 2015;19(2):149-156.]Search in Google Scholar
[47. Han JC, Liu QR, Jones M, Levinn RL, et al. Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med. 2008;359(9):918-927.10.1056/NEJMoa0801119255370418753648]Search in Google Scholar
[48. Rodriguez-Lopez R, Perez JM, Balsera AM, et al. The modifier effect of the BDNF gene in the phenotype of the WAGRO syndrome. Gene. 2013;516(2):285-290.10.1016/j.gene.2012.11.07323266638]Search in Google Scholar
[49. Gucev Z, Muratovska O, Laban N, et al. Billateral polycystic kidneys in a girl with WAGR syndrome. Indian J Pediatr. 2011;78(10):1290-1292.10.1007/s12098-011-0457-221660403]Search in Google Scholar
[50. Montague CT, Farooqi IS, Whitehead JP, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature. 1997;387(6636):903-908.10.1038/431859202122]Search in Google Scholar
[51. Gibson WT, Farooqi IS, Moreau M, et al. Congenital leptin deficiency due to homozygosity for the Delta133G mutation: report of another case and evaluation of response to four years of leptin therapy. J Clin Endocrinol Metab. 2004;89(10):4821-4826.10.1210/jc.2004-037615472169]Search in Google Scholar
[52. Mazen I, El-Gammal M, Abdel-Hamid M, Amr K. A novel homozygous missense mutation of the leptin gene (N103K) in an obese Egyptian patient. Mol Genet Metab. 2009;97(4):305-308.10.1016/j.ymgme.2009.04.00219427251]Search in Google Scholar
[53. Wabitsch M, Funcke JB, Lennerz B, et al. Biologically inactive leptin and early-onset extreme obesity. N Engl J Med. 2015;372:48-54.10.1056/NEJMoa140665325551525]Search in Google Scholar
[54. Cl´ement K, Vaisse C, Lahlou N. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature. 1998;392(6674):398-401.10.1038/329119537324]Search in Google Scholar
[55. Farooqi IS, Wangensteen T, Collins S. Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med. 2007;356(3):237-247.10.1056/NEJMoa063988267019717229951]Search in Google Scholar
[56. Saeed S, Bonnefond A, Manzoor J, et al. Novel LEPR mutations in obese Pakistani children identified by PCR-based enrichment and next generation sequencing. Obesity. 2014;22(4):1112-1117.10.1002/oby.2066724319006]Open DOISearch in Google Scholar
[57. Huvenne H, Beyec J, P´epin D, et al. Seven novel deleterious LEPR mutations found in early-onset obesity: a ΔExon6-8 shared by subjects from Reunion Island, France, suggests a founder effect. J Clin Endocrinol Metab. 2015;100(5):E757-E66.10.1210/jc.2015-103625751111]Search in Google Scholar
[58. Farooqi, IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110(8):1093-1103.10.1172/JCI0215693]Search in Google Scholar
[59. Simonds SE, Pryor JT, Ravussin E, et al. Leptin mediates the increase in blood pressure associated with obesity. Cell. 2014;159(6):1404-1416.10.1016/j.cell.2014.10.058425949125480301]Search in Google Scholar
[60. Farooqi IS, Jebb SA, Langmack G, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999;341:879-884.10.1056/NEJM19990916341120410486419]Search in Google Scholar
[61. Doche ME, Bochukova EG, Su HW, et al. Human SH2B1 mutations are associated with maladaptive behaviors and obesity. J Clin Invest. 2012; 122(12):4732-4736.10.1172/JCI62696353353523160192]Search in Google Scholar
[62. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet. 1998;19(2):155-157.10.1038/5099620771]Open DOISearch in Google Scholar
[63. Farooqi IS, Drop S, Clements A, et al. Heterozygosity for a POMC-null mutation and increased obesity risk in humans. Diabetes. 2006; 55(9):2549-2553.10.2337/db06-021416936203]Open DOISearch in Google Scholar
[64. Krude H, Biebermann H, Gruters A. Mutations in the human proopiomelanocortin gene. Ann N Y Acad Sci. 2003;994:233-239.10.1111/j.1749-6632.2003.tb03185.x12851321]Search in Google Scholar
[65. Ozen S, Ozcan N, Ucar SK, Goksen D, Darcan S. Unexpected clinical features in a female patient with proopiomelanocortin (POMC) deficiency. J Pediatr Endocrinol Metab. 2015;28(5-6):691-694.10.1515/jpem-2014-032425503863]Search in Google Scholar
[66. Farooqi IS, Volders K, Stanhope R, et al. Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3. J Clin Endocrinol Metab. 2007;92(9):3369-3373.10.1210/jc.2007-068717595246]Search in Google Scholar
[67. Jackson RS, Creemers JW, Farooqi IS. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 2003:112(10):1550-1560.10.1172/JCI200318784]Search in Google Scholar
[68. Jackson RS, Creemers JW, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet. 1997;16(3):303–30610.1038/ng0797-3039207799]Search in Google Scholar
[69. Frank GR., Fox J, Candela N, et al. Severe obesity and diabetes insipidus in a patient with PCSK1 deficiency. Mol Genet Metab. 2013;110(1-2):191-194.10.1016/j.ymgme.2013.04.005375984523800642]Search in Google Scholar
[70. Martín MG, Lindberg I, Solorzano-Vargas RS, et al. Congenital Proprotein Convertase 1/3 Deficiency Causes Malabsorptive Diarrhea and other Endocrinopathies in a Pediatric Cohort. Gastroenterology. 2013;145(1):138-148.10.1053/j.gastro.2013.03.048371913323562752]Search in Google Scholar
[71. Yourshaw M, Solorzano-Vargas RS, Pickett LA, et al. Exome Sequencing Finds a Novel PCSK1 Mutation in a Child With Generalized Malabsorptive Diarrhea and Diabetes Insipidus. J Pediatr Gastroenterol Nutr. 2013;57(6):759-767.10.1097/MPG.0b013e3182a8ae6c417006224280991]Search in Google Scholar
[72. Philippe J, Stijnen P, Meyre D, et al. A nonsense loss-of-function mutation in PCSK1contributes to dominantly inherited human obesity. Int J Obes. 2015;39(2):295-302.10.1038/ijo.2014.9624890885]Search in Google Scholar
[73. Dubern B, Bisbis S, Talbaoui H, et al. Homozygous null mutation of the melanocortin-4 receptor and severe early-onset obesity. J Pediatr. 2007;150(6):613-617.e1.10.1016/j.jpeds.2007.01.04117517245]Search in Google Scholar
[74. Garg G, Kumar J, McGuigan FE, et al. Variation in the MC4R Gene Is Associated with Bone Phenotypes in Elderly Swedish Women. Devaney J, ed. PLoS One. 2014;9(2):e88565.10.1371/journal.pone.0088565391644024516669]Search in Google Scholar
[75. Timpson NJ, Sayers A, Davey-Smith G, Tobias JH. How does body fat influence bone mass in childhood? A Mendelian randomization approach. J Bone Miner Res. 2009;24(3):522-533.10.1359/jbmr.081109287516519016587]Open DOISearch in Google Scholar
[76. Farooqi IS, Yeo GS, Keogh JM, et al. Dominant andrecessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency. J Clin Invest. 2000;106(2):271-279.10.1172/JCI9397]Search in Google Scholar
[77. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O’Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003;348(12):1085-1095.10.1056/NEJMoa022050]Search in Google Scholar
[78. Yeo GS, Conie Hung CC, Rochford, J, et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci. 2004;7(11):1187-1189.10.1038/nn1336]Search in Google Scholar
[79. Gray J, Yeo GS, Cox JJ, et al. Hyperphagia, severe obesity, impaired cognitiven function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene. Diabetes. 2006;55(12):3366-3371.10.2337/db06-0550]Open DOISearch in Google Scholar
[80. Michaud JL, DeRossi C, May NR, Holdener BC, Fan CM. ARNT2 acts as the dimerization partner of SIM1 for the development of the hypothalamus. Mech Dev. 2000;90(2):253-261.10.1016/S0925-4773(99)00328-7]Search in Google Scholar
[81. Michaud JL, Rosenquist T, May NR, Fan CM. Development of neuroendocrine lineages requires the bHLH–PAS transcription factor SIM1. Genes Dev. 1998;12(20):3264-3275.10.1101/gad.12.20.32643172169784500]Search in Google Scholar
[82. Michaud JL, Boucher F, Melnyk A. Sim1 haploinsufficiency causes hyperphagia, obesity and reduction of the paraventricular nucleus of the hypothalamus. Hum Mol Genet. 2001;10(14): 1465-1473.10.1093/hmg/10.14.146511448938]Search in Google Scholar
[83. Holder JL, Butte NF, Zinn AR. Profound obesity associated with a balanced translocation that disrupts the SIM1 gene. Hum Mol Genet. 2000;9:101-108.10.1093/hmg/9.1.10110587584]Search in Google Scholar
[84. Bonnefond A, Raimondo A, Stutzmann F, et al. Loss-of-function mutations in SIM1 contribute to obesity and Prader-Willi–like features. J Clin Invest. 2013;123(7):3037-3041.10.1172/JCI68035369655923778136]Search in Google Scholar
[85. Montagne L, Raimondo A, Delobel B, et al. Identification of two novel loss-of-function SIM1 mutations in two overweight children with developmental delay. Obesity. 2014;22(12):2621-2624.10.1002/oby.2088625234154]Search in Google Scholar
[86. Ramachandrappa S, Raimondo A, Cali AMG, et al. Rare variants in single-minded 1 (SIM1) are associated with severe obesity. J Clin Invest. 2013;123(7):3042-3050.10.1172/JCI68016369655823778139]Search in Google Scholar
[87. Pearce LR, Atanassova N, Banton MC, et al. KSR2 Mutations Are Associated with Obesity, Insulin Resistance, and Impaired Cellular Fuel Oxidation. Cell. 2013;155(4):765-777.10.1016/j.cell.2013.09.058389874024209692]Search in Google Scholar
[88. Borman AD, Pearce LR, Mackay DS, et al. A Homozygous Mutation in the TUB Gene Associated with Retinal Dystrophy and Obesity. Hum Mutat. 2014;35(3):289-293.10.1002/humu.22482428401824375934]Open DOISearch in Google Scholar
[89. Choquet H, Meyre D. Molecular Basis of Obesity: Current Status and Future Prospects. Curr Genomics. 2011;12(3):154-168.10.2174/138920211795677921313700122043164]Search in Google Scholar
[90. Choquet H, Meyre D. Genetics of Obesity: What have we Learned? Curr Genomics. 2011;12(3):169-179.10.2174/138920211795677895313700222043165]Open DOISearch in Google Scholar
[91. Stutzmann F, Tan K, Vatin V, et al. Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes. 2008;57(9):2511-2518.10.2337/db08-0153251850418559663]Open DOISearch in Google Scholar
[92. Stanikova D, Surova M, Buzga M, et al. Age of obesity onset in MC4R mutation carriers. Endocr Regul. 2014;49(3):137-140.10.4149/endo_2015_03_13726238496]Search in Google Scholar
[93. Biebermann H, Castaneda TR, van Landeghem F, et al. A role for β-melanocyte-stimulating hormone in human body-weight regulation. Cell Metab. 2006;3(2):141-146.10.1016/j.cmet.2006.01.00716459315]Open DOISearch in Google Scholar
[94. Challis BG, Pritchard LE, Creemers JW, et al. A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism. Hum Mol Genet. 2002;11(17):1997-2004.10.1093/hmg/11.17.199712165561]Search in Google Scholar
[95. Lee YS, Challis BG, Thompson DA, et al. A POMC variant implicates β-melanocyte-stimulating hormone in the control of human energy balance. Cell Metab. 2006;3(2):135-140.10.1016/j.cmet.2006.01.00616459314]Open DOISearch in Google Scholar
[96. Farooqi IS, Keogh JM, Kamath S, et al. Metabolism: partial leptin deficiency and human adiposity. Nature. 2001;414(6859):34-35.10.1038/3510211211689931]Search in Google Scholar
[97. Cummings DE, Schwartz MW. Genetics and pathophysiology of human obesity. Annu Rev Med. 2003;54:453-471.10.1146/annurev.med.54.101601.15240312414915]Open DOISearch in Google Scholar
[98. Meyre D, Bouatia-Naji N, Tounian A, et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet. 2005;37(8):863-867.10.1038/ng1604200080416025115]Search in Google Scholar
[99. Meyre D, Lecoeur C, Delplanque J, et al. A genome-wide scan for childhood obesity-associated traits in French families shows significant linkage on chromosome 6q22.31-q23.2. Diabetes. 2004;53(3):803-811.10.2337/diabetes.53.3.80314988267]Search in Google Scholar
[100. Wang R, Zhou D, Xi B, et al. ENPP1/PC-1 gene K121Q polymorphism is associated with obesity in European adult populations: evidence from a meta-analysis involving 24,324 subjects. Biomed Environ Sci. 2011;24(2):200-206.]Search in Google Scholar
[101. Warrington NM, Howe LD, Paternoster L, et al. A genome-wide association study of body mass index across early life and childhood. Int J Epidemiol. 2015;44(2):700-712.10.1093/ije/dyv077446979825953783]Search in Google Scholar
[102. Bradfield JP, Taal HR, Timpson NJ, et al. A genome-wide association meta-analysis identifies new childhood obesity loci. Nat Genet. 2012;44(5):526-531.10.1038/ng.2247337010022484627]Open DOISearch in Google Scholar
[103. Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015;518(7538):197-206.10.1038/nature14177438221125673413]Search in Google Scholar
[104. Meyre D, Delplanque J, Chevre JC, et al. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet. 2009;41(2):157-159.10.1038/ng.30119151714]Open DOISearch in Google Scholar
[105. Li A, Meyre D. Jumping on the Train of Personalized Medicine: A Primer for Non-Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area. Curr Psychiatry Rev. 2014;10(2):118-132.10.2174/1573400510666140630170549428788425598768]Search in Google Scholar
[106. Bonnefond A, Philippe J, Durand E, et al. Highly sensitive diagnosis of 43 monogenic forms of diabetes or obesity through one-step PCR-based enrichment in combination with next-generation sequencing. Diabetes Care. 2014;37(2):460-467.10.2337/dc13-069824041679]Open DOISearch in Google Scholar
[107. Philippe J, Derhourhi M, Durand E, et al. What Is the Best NGS Enrichment Method for the Molecular Diagnosis of Monogenic Diabetes and Obesity? Brusgaard K, ed. PLoS One. 2015;10(11):e0143373.10.1371/journal.pone.0143373465789726599467]Search in Google Scholar
[108. Hinney A, Wolters B, Pütter C, et al. J Pediatr Endocrinol Metab. 2013;26(11-12):1209-1213.10.1515/jpem-2013-017923843577]Open DOISearch in Google Scholar
[109. Reinehr T, Wolters B, Roth CL, Hinney A. (2014) FTO gene: association to weight regain after lifestyle intervention in overweight children. Horm Res Paediatr. 2014;81(6):391-396.10.1159/00035832824819256]Search in Google Scholar
[110. Qi L. Gene–diet interaction and weight loss. Curr Opinion Lipid. 2014;25(1):27-34.10.1097/MOL.0000000000000037533019824345984]Search in Google Scholar
[111. Le Beyec J, Cugnet-Anceau C, Pepin D, et al. Homozygous leptin receptor mutation due to uniparental disomy of chromosome 1: response to bariatric surgery. J Clin Endocrinol Metab. 2013;98(2):E397-E402.10.1210/jc.2012-277923275530]Search in Google Scholar
[112. Aslan IR, Campos GM, Calton MA, Evans DS, Merriman RB, Vaisse C. Weight Loss after Roux-en-Y Gastric Bypass in Obese Patients Heterozygous for MC4R Mutations. Obes Surg. 2011;21(7):930-934.10.1007/s11695-010-0295-8311979820957447]Open DOISearch in Google Scholar
[113. Hatoum IJ, Stylopoulos N, Vanhoose AM, et al. Melanocortin-4 Receptor Signaling Is Required for Weight Loss after Gastric Bypass Surgery. J Clin Endocrinol Metabol. 2012;97(6):E1023-E1031.10.1210/jc.2011-3432338741222492873]Search in Google Scholar
[114. Valette M, Poitou C, Le Beyec J, Bouillot J-L, Clement K, Czernichow S. Melanocortin-4 Receptor Mutations and Polymorphisms Do Not Affect Weight Loss after Bariatric Surgery. Folli F, ed. PLoS One. 2012;7(11):e48221.10.1371/journal.pone.0048221350404523185251]Search in Google Scholar
[115. Meyre D, Froguel P, Horber FF, Kral JG. Comment On: Valette et al. Melanocortin-4 Receptor Mutations and Polymorphisms Do Not Affect Weight Loss after Bariatric Surgery. PLoS One. 2012;7(11):E48221. Folli F, ed. PLoS One. 2014;9(3):e93324.10.1371/journal.pone.0093324]Search in Google Scholar
[116. Moore BS, Mirshahi UL, Yost EA, et al. Long-Term Weight-Loss in Gastric Bypass Patients Carrying Melanocortin 4 Receptor Variants. López M, ed. PLoS One. 2014;9(4):e93629.10.1371/journal.pone.0093629397631824705671]Search in Google Scholar
[117. Sarzynski MA, Jacobson P, Rankinen, T, et al. Associations of markers in 11 obesity candidate genes withmaximal weight loss and weight regain in the SOS bariatric surgery cases. Int J Obes. 2011;35(5):676-683.10.1038/ijo.2010.16620733583]Search in Google Scholar
[118. Hatoum IJ, Greenawalt DM, Cotsapas C, Daly MJ, Reitman ML, Kaplan LM. Weight Loss after Gastric Bypass Is Associated with a Variant at 15q26.1. Am J Hum Genet. 2013;92(5):827-834.10.1016/j.ajhg.2013.04.009364464223643386]Search in Google Scholar
[119. Fujioka K. Safety and tolerability of medications approved for chronic weight management. Obesity. 2015;23(Suppl 1):S7-S11.10.1002/oby.2109425900872]Search in Google Scholar
[120. Lazary J, Juhasz G, Hunyady L, Bagdy G. Personalized medicine can pave the way for the safe use of CB(1) receptor antagonists. Trends Pharmacol Sci. 2011;32(5):270-280.10.1016/j.tips.2011.02.01321497918]Search in Google Scholar
[121. Bjorge T, Engeland A, Tverdal A, Smith GD. Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230,000 Norwegian adolescents. Am J Epidemiol. 2008;168(1):30-37.10.1093/aje/kwn09618477652]Search in Google Scholar
[122. Gordon JE, Hughes MS, Shepherd K, et al. Obstructive sleep apnoea syndrome in morbidly obese children with tibia vara. J Bone Joint Surg Br. 2006;88(1):100-103.10.1302/0301-620X.88B1.1691816365129]Search in Google Scholar
[123. Murray AW, Wilson NI. Changing incidence of slipped capital femoral epiphysis: a relationship with obesity? J Bone Joint Surg Br. 2008;90(1):92-94.10.1302/0301-620X.90B1.19502]Search in Google Scholar
[124. Timpson NJ, Sayers A, Davey-Smith G, Tobias JH. How does body fat influence bone mass in childhood? A Mendelian randomization approach. J Bone Miner Res. 2009;24(3):522-533.10.1359/jbmr.081109287516519016587]Open DOISearch in Google Scholar
[125. Tirosh A, Shai I, Afek A, Dubnov-Raz G, et al. Adolescent BMI trajectory and risk of diabetes versus coronary disease. N Engl J Med. 2011;364(14):1315-1325.10.1056/NEJMoa1006992493925921470009]Search in Google Scholar
[126. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012;307(5):483-490.10.1001/jama.2012.40636245222253364]Search in Google Scholar
[127. Calcaterra V, Klersy C, Muratori T, et al. Prevalence of metabolic syndrome (MS) in children and adolescents with varying degrees of obesity. Clin Endocrinol (Oxf). 2008;68(6):868-872.10.1111/j.1365-2265.2007.03115.x17980007]Search in Google Scholar
[128. Rosenfield RL, Lipton RB, Drum ML. Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index. Pediatrics. 2009;123(1):84-88.10.1542/peds.2008-014619117864]Search in Google Scholar
[129. Bau AM, Ernert A, Schenk L, et al. Is there a further acceleration in the age at onset of menarche? A cross-sectional study in 1840 school children focusing on age and bodyweight at the onset of menarche. Eur J Endocrinol. 2009;160(1):107-113.10.1530/EJE-08-059418974233]Search in Google Scholar
[130. Mamun AA, Hayatbakhsh MR, O’Callaghan M, Williams G, Najman J. Early overweight and pubertal maturation—pathways of association with young adults’ overweight: a longitudinal study. Int J Obes (Lond). 2009;33(1):14-20.10.1038/ijo.2008.22018982007]Search in Google Scholar
[131. Denzer C, Weibel A, Muche R, Karges B, Sorgo W, Wabitsch M. Pubertal development in obese children and adolescents. Int J Obes (Lond). 2007;31(10):1509-1519.10.1038/sj.ijo.080369117653066]Search in Google Scholar
[132. Taylor ED, Theim KR, Mirch MC, et al. Orthopedic complications of overweight in children and adolescents. Pediatrics. 2006; 117(6):2167-2174.10.1542/peds.2005-1832186300716740861]Search in Google Scholar
[133. DiVall SA, Radovick S. Endocrinology of female puberty. Curr Opin Endocrinol Diabetes Obes. 2009;16(1):1-4.10.1097/MED.0b013e3283207937]Search in Google Scholar
[134. Coffield JE, Metos JM, Utz RL, Waitzman NJ. A multivariate analysis of federally mandated school wellness policies on adolescent obesity. J Adolesc Health. 2011;49(4):363-70.10.1016/j.jadohealth.2011.01.01021939866]Search in Google Scholar
[135. Kalarchian MA, Levine MD, Arslanian SA, et al. Family-based treatment of severe pediatric obesity: randomized, controlled trial. Pediatrics. 2009;124(4):1060-1068.10.1542/peds.2008-3727293549419786444]Search in Google Scholar
[136. Ortega FB, Labayen I, Ruiz JR, et al. Improvements in fitness reduce the risk of becoming overweight across puberty. Med Sci Sports Exerc. 2011;43(10):1891-1897.10.1249/MSS.0b013e3182190d7121407124]Search in Google Scholar
[137. Chang S-H, Stoll CRT, Song J, Varela E, Eagon CJ, Colditz G a. Bariatric surgery: an updated systematic review and meta analysis, 2003–2012. JAMA Surg. 2014;149(3):275-287.10.1001/jamasurg.2013.3654396251224352617]Search in Google Scholar
[138. Cummings DE, Overduin J, Foster-Schubert KE. Gastric Bypass for Obesity : Mechanisms of Weight Loss and Diabetes Resolution. J Clin Endocrinol Metab. 2015;89(6):2608-2615.10.1210/jc.2004-043315181031]Search in Google Scholar
[139. Chapman AE, Hons BA, Kiroff G, Game P. Clinical review Laparoscopic adjustable gastric banding in the treatment of obesity : A systematic literature review. Surgery. 2004;153(3):326-351.10.1016/S0039-6060(03)00392-1]Search in Google Scholar